文献速递神经MR

Wave-CAIPI在增强3D T1-SPACE评估脑转移瘤中的价值

Usefulness of Wave-CAIPI for Postcontrast 3D T1-SPACE in the Evaluation of Brain Metastases.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-05-26

回顾性纳入56例疑似脑转移瘤患者,比较增强Wave-T1-SPACE与标准T1-SPACE。两种序列对大于5mm强化病灶检出无显著差异,但Wave-T1-SPACE对小于5mm病灶检出数显著低于标准序列,且对比噪声比和整体图像质量更低;作者认为Wave-T1-SPACE评估脑转移瘤时应谨慎解读。

要点

  • Wave-T1-SPACE对大于5mm强化病灶检出与标准SPACE无显著差异。
  • Wave-T1-SPACE对小于5mm强化病灶检出数显著低于标准SPACE。
  • Wave-T1-SPACE的病灶/脑实质对比噪声比及整体图像质量显著低于标准SPACE。

核心结论

  • 增强Wave-T1-SPACE对大于5mm强化病灶诊断性能与标准SPACE相当且扫描时间明显缩短,但对小于5mm强化病灶存在低估且图像质量较低,评估脑转移瘤时应谨慎解读。

研究设计与样本

  • 回顾性研究,从387例接受增强Wave-T1-SPACE和标准SPACE检查的患者中纳入56例疑似脑转移瘤患者,由2名神经放射科医生评估。

关键影像表现/征象

  • 比较两种序列上强化病灶数目(按病灶大小分组)、病灶/脑实质对比噪声比、白质/灰质对比噪声比、病灶/脑实质对比率及整体图像质量。
  • Wave-T1-SPACE整体图像质量显著低于标准SPACE。
  • Wave-T1-SPACE病灶/脑实质对比噪声比显著低于标准SPACE。

诊断标准与关键数值

  • 大于5mm强化病灶检出数:观察者1 P=.66,观察者2 P=.26,两种序列无显著差异。
  • 小于5mm强化病灶检出数:观察者1 Wave-T1-SPACE 1.61(SD 0.29)vs 标准SPACE 2.84(SD 0.47);观察者2 Wave-T1-SPACE 1.41(SD 0.19)vs 标准SPACE 2.68(SD 0.43),Wave-T1-SPACE显著低于标准SPACE。

临床应用与阅片要点

  • 作者认为增强Wave-T1-SPACE评估脑转移瘤时应谨慎解读。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: High-resolution postcontrast 3D T1WI is a widely used sequence for evaluating brain metastasis, despite the long scan time. This study aimed to compare highly accelerated postcontrast 3D T1-weighted sampling perfection with application-optimized contrasts by using different flip angle evolution by using wave-controlled aliasing in parallel imaging (wave-T1-SPACE) with the commonly used standard high-resolution postcontrast 3D T1-SPACE for the evaluation of brain metastases.

MATERIALS AND METHODS: Among the 387 patients who underwent postcontrast wave-T1-SPACE and standard SPACE, 56 patients with suspected brain metastases were retrospectively included. Two neuroradiologists assessed the number of enhancing lesions according to lesion size, contrast-to-noise ratiolesion/parenchyma, contrast-to-noise ratiowhite matter/gray matter, contrast ratiolesion/parenchyma, and overall image quality for the 2 different sequences.

RESULTS: Although there was no significant difference in the evaluation of larger enhancing lesions (>5 mm) between the 2 different sequences (P = .66 for observer 1, P = .26 for observer 2), wave-T1-SPACE showed a significantly lower number of smaller enhancing lesions (<5 mm) than standard SPACE (1.61 [SD, 0.29] versus 2.84 [SD, 0.47] for observer 1; 1.41 [SD, 0.19] versus 2.68 [SD, 0.43] for observer 2). Furthermore, mean contrast-to-noise ratiolesion/parenchyma and overall image quality of wave-T1-SPACE were significantly lower than those in standard SPACE.

CONCLUSIONS: Postcontrast wave-T1-SPACE showed comparable diagnostic performance for larger enhancing lesions (>5 mm) and marked scan time reduction compared with standard SPACE. However, postcontrast wave-T1-SPACE showed underestimation of smaller enhancing lesions (<5 mm) and lower image quality than standard SPACE. Therefore, postcontrast wave-T1-SPACE should be interpreted carefully in the evaluation of brain metastasis.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Baek HJ, Heo YJ, Kim D, et al. Usefulness of Wave-CAIPI for Postcontrast 3D T1-SPACE in the Evaluation of Brain Metastases. AJNR Am J Neuroradiol. 2022. PMID: 35618423. doi:10.3174/ajnr.A7520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。